The prevalence and risk factors of lower limb lymphedema in the patients with gynecologic neoplasms.
- Author:
Seung Hoon KANG
1
;
Ki Hun HWANG
;
Young Joo SIM
;
Ho Joong JEONG
;
Tae Hwa LEE
;
Sung Han KIM
Author Information
1. Department of Physical Medicine and Rehabilitation, Dong-eui Hospital, Busan, Korea.
- Publication Type:Original Article
- Keywords:
Lymphedema;
Gynecologic neoplasms;
Risk factor
- MeSH:
Body Mass Index;
Female;
Follow-Up Studies;
Genital Neoplasms, Female;
Humans;
Hysterectomy;
Korea;
Logistic Models;
Lower Extremity;
Lymph Node Excision;
Lymphedema;
Medical Records;
Multivariate Analysis;
Prevalence;
Retrospective Studies;
Risk Factors
- From:Korean Journal of Obstetrics and Gynecology
2009;52(8):815-820
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: To identify the prevalence and risk factors for lower limb lymphedema in the patients after gynecologic neoplasms treatment in Korea. METHODS: We retrospectively reviewed the medical records and interviewed 242 gynecologic neoplasms patients who have managed surgically and medically over a 4 year period between January 2003 and December 2006. We identified the patients with lower limb lymphedema as described by the medical records or reported by the interviews. We obtained demographic characteristics, other medical history, cancer type, stage of cancer, lymph node dissection, chemotherapy, radiotherapy, hormone therapy and laboratory findings. Multiple logistic regression analysis was done to evaluate the risk factors for lower limb lymphedema. RESULTS: Forty eight (19.8%) patients out of two hundred forty two had lower limb lymphedema. Those patients with lower limb lymphedema had a higher body mass index, radiotherapy history, chemotherapy history and lymph node dissection history, radical hysterectomy. Multivariate analysis revealed that body mass index, radiotherapy and lymph node dissection were independently risk factors for lower limb lymphedema after gynecologic neoplasms treatment. CONCLUSION: The patients who had radiotherapy, body mass index greater than 25 or lymph node dissection must be considered as potential candidates to have lower limb lymphedema in the patients after gynecologic neoplasms treatment. Therefore, these patients should be informed during the follow-up period about this morbidity, the preventive measures, and the treatments.
